IRadimed Corporation (IRMD)
After hours:
| Previous close | 40.90 |
| Open | 41.34 |
| Bid | 40.54 x 200 |
| Ask | 40.79 x 300 |
| Day's range | 40.61 - 41.34 |
| 52-week range | 36.12 - 51.04 |
| Volume | |
| Avg. volume | 51,559 |
| Market cap | 514.293M |
| Beta (5Y monthly) | 0.86 |
| PE ratio (TTM) | 30.08 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.15 (0.37%) |
| Ex-dividend date | 21 Dec 2023 |
| 1y target est | N/A |
- GlobeNewswire
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
WINTER SPRINGS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market opens on Thursday, May 2, 2024. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, https://register.vevent.com/
- GlobeNewswire
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
WINTER SPRINGS, Fla., March 13, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that Roger Susi, the Company's President and Chief Executive Officer, will present at the 36th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is scheduled for a live fireside chat on Tuesday, March 19, at 12:30 p.m. PT. A live webcast and a replay of the fireside chat will be available on Iradimed’s Investor page at https://www.iradimed.com/investors/events. This ye
- GlobeNewswire
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
Reports record revenue of $17.5 million for the fourth quarter and $65.6 million for the full year of 2023. Reports GAAP diluted EPS of $0.36 and non-GAAP diluted EPS of $0.39 for the fourth quarter of 2023. Reports GAAP diluted EPS of $1.35 and non-GAAP diluted EPS of $1.48 for the full year of 2023. Reports fourth quarter of 2023 operating income of $5.2 million, an increase of 21.3%, compared to the same period in 2022 and full-year operating income of $20.0 million, an increase of 28.2%, com
